Coenzyme Q10
(Ubiquinol)
The mitochondrial energy catalyst and potent antioxidant for heart health, fertility, and cellular vitality
Coenzyme Q10 (CoQ10), available as ubiquinone or ubiquinol, is a fat-soluble compound essential for ATP production within mitochondria and cellular protection against oxidative stress. Decades of clinical research support its use for cardiovascular health, energy production, fertility enhancement, and as adjunctive support for statin users experiencing muscle-related side effects.
Coenzyme Q10 has strong evidence for cardiovascular benefits (heart failure, hypertension, endothelial function), fertility enhancement (male and female), statin-induced myopathy relief, migraine prevention, metabolic control, and anti-inflammatory effects. Moderate evidence supports benefits in fatigue, fibromyalgia, MS, depression, skin aging, and athletic performance. Evidence limited but promising for neurodegenerative diseases, hearing preservation, and kidney disease. Over 200 RCTs support safety and tolerability at doses up to 1200 mg/day. Formulation quality and bioavailability vary significantly; ubiquinol with dispersed formulation shows superior bioavailability. Interaction with warfarin requires monitoring; synergistic benefit with selenium established. Recommended 100–300 mg/day with fat-containing meals; higher doses (300–600 mg/day) used in specific clinical conditions.
Cardiovascular Health & Heart Failure
StrongCoQ10 improves cardiac function, reduces cardiovascular mortality by ~43%, and decreases hospitalizations in heart failure patients. The Q-SYMBIO trial (n=420) showed 300 mg/day reduced major adverse cardiovascular events and improved NYHA functional class. A 2024 meta-analysis (n=2,350) confirmed significant reductions in all-cause mortality (RR 0.64) and HF hospitalizations (RR 0.50), with improvements in ejection fraction and 6-minute walk distance.
Hypertension Management
StrongMeta-analysis of 12 clinical trials (362 patients) demonstrated CoQ10 reduces systolic blood pressure by 16.6 mm Hg and diastolic by 8.2 mm Hg in RCTs without significant adverse effects. Optimal benefit observed at 100–200 mg/day dosing. Effect appears dose-dependent and is thought mediated through improved endothelial function and increased nitric oxide availability.
Male Fertility Enhancement
StrongRandomized controlled trials show CoQ10 supplementation significantly increases total sperm count (SMD −13.38), total motility (SMD −7.26), progressive motility (SMD −6.39), and percentage of normally formed sperm (SMD −1.96). Serum testosterone and inhibin B levels increased; LH and FSH decreased. CoQ10 improves sperm mitochondrial function and reduces oxidative stress in male gametes.
Female Fertility & Oocyte Quality
StrongCoQ10 supplementation improves oocyte quality, ovarian function, and embryo grade in women undergoing IVF/ART. Oral administration of 200 mg/day for 30–35 days increases follicular fluid CoQ10 levels, correlating with improved embryo morphokinetics and higher pregnancy rates. Benefits pronounced in women of advanced reproductive age and poor ovarian reserve, potentially through enhanced mitochondrial bioenergetics and oxidative stress reduction.
Statin-Induced Myopathy Relief
StrongSystematic reviews and meta-analyses consistently show CoQ10 supplementation (50–200 mg/day) significantly reduces statin-associated muscular symptoms, including pain, weakness, cramps, and fatigue, without notable adverse effects. Statins inhibit CoQ10 biosynthesis; supplementation restores levels to prevent muscle membrane damage and mitochondrial dysfunction. Efficacy independent of statin type or dose.
Migraine Prevention & Symptom Reduction
StrongMultiple RCTs demonstrate CoQ10 (100–400 mg/day for 8–12 weeks) significantly reduces migraine frequency, duration, severity, and associated nausea, light sensitivity, and noise sensitivity. Mechanism involves improved mitochondrial energy supply to neurons and anti-inflammatory/antioxidant activity. Dose-dependent effects observed; 400 mg/day showed particular efficacy in women.
Metabolic & Glycemic Control
StrongMeta-analysis of 40 RCTs (2,157 participants) shows CoQ10 supplementation reduces fasting glucose (WMD −5.22 mg/dL), fasting insulin, HbA1c, and HOMA-IR with optimal benefit at 100–200 mg/day for ≥12 weeks duration. Improves insulin sensitivity and antioxidant capacity; particularly beneficial in diabetes patients.
Athletic Performance & Fatigue Recovery
ModerateSystematic review of CoQ10 in athletes (30–300 mg) shows reduced fatigue markers (creatine kinase), improved anaerobic performance (muscle power, anaerobic threshold), decreased oxidative stress and inflammatory markers, and enhanced liver function. No significant effect on aerobic capacity. Benefits attributed to enhanced ATP production and antioxidant activity reducing exercise-induced muscle damage.
Chronic Fatigue & Myalgic Encephalomyelitis (ME/CFS)
ModerateRandomized trials show CoQ10 supplementation (200–500 mg/day for 8–12 weeks) significantly reduces fatigue severity, improves quality of life, sleep duration and efficiency, and reduces pain in ME/CFS patients. Combined CoQ10 + selenium shows synergistic benefit in modulating oxidative stress and inflammation. Mechanism involves restoration of mitochondrial bioenergetics in energy-depleted conditions.
Endothelial Function & Vascular Health
StrongMeta-analysis of 5 RCTs (194 patients) demonstrates CoQ10 supplementation significantly improves flow-mediated dilation (SMD 1.70), a key measure of endothelial function. Benefits particularly pronounced in patients with pre-existing endothelial dysfunction. Mechanism involves reduced ROS production in vascular system and increased NO availability for vasodilation.
Inflammation Reduction
ModerateUmbrella review of meta-analyses shows CoQ10 supplementation (60–500 mg/day, median 200 mg/day for median 12 weeks) significantly decreased pro-inflammatory cytokines IL-6 and TNF-α in majority of meta-analyses, and CRP in subset of studies. Mechanism involves PPAR-γ-mediated inhibition of NFκB activation. Benefit observed across multiple inflammatory conditions.
Fibromyalgia Pain & Fatigue
ModerateRCTs show CoQ10 (300 mg/day for 40 days or 100 mg/day for 3 months) significantly reduces chronic pain, fatigue, and morning tiredness in fibromyalgia patients with corresponding improvement in mitochondrial bioenergetic function and reduced oxidative stress/inflammatory markers. Adolescents with juvenile fibromyalgia also respond to 100 mg/day ubiquinol.
Depression & Mental Health
LimitedRCT (69 patients) shows 200 mg CoQ10 daily for 8 weeks alongside standard depression treatment significantly reduces depression symptoms on Montgomery-Åsberg scale, improves quality of life, and modulates oxidative stress status. Mechanism involves antioxidant protection of mitochondria and reduced neuroinflammation.
Skin Aging & Wrinkle Reduction
ModerateTopical and oral CoQ10 reduces wrinkle depth and improves skin roughness in aging skin. In vivo/ex vivo studies show CoQ10 penetrates to dermal layers, restores cellular energy homeostasis, and enhances antioxidant defense against photoaging. Clinical improvements in fine lines and crepey skin observed after 4–6 weeks of consistent topical application.
Neurodegenerative Disease Support
LimitedPreclinical and early clinical evidence suggests CoQ10 may provide neuroprotective benefits in Parkinson's disease (ubiquinol more effective than ubiquinone), Alzheimer's disease, and Huntington's disease through mitochondrial bioenergetics enhancement and oxidative stress reduction. Animal models show consistent benefit; human trials show mixed results with high-dose ubiquinol (300 mg/day, 48 weeks) showing benefit in PD wearing off.
Periodontal & Gum Health
LimitedRCT showed oral CoQ10 supplements (as adjunct to scaling/root planing) significantly reduce gingival inflammation compared to mechanical therapy alone. Deficiency of CoQ10 in inflamed gingiva linked to periodontal destruction; supplementation restores metabolic energy and anti-inflammatory activity in periodontal tissues.
Hearing Preservation & Tinnitus
ModerateDouble-blind RCT (50 patients) shows 100 mg CoQ10 daily significantly decreases tinnitus disability and loudness, improves sleep disturbance in presbycusis-related tinnitus. CoQ10 replacement therapy in primary CoQ10 deficiency-6 (COQ10D6) patients showed 42.9% response rate (hearing stabilization or improvement). Mechanism involves mitochondrial energy support for auditory hair cells.
Multiple Sclerosis & Autoimmune Support
ModerateRCT (48 MS patients) shows 500 mg/day CoQ10 for 3 months significantly reduces IL-6 and TNF-α, improves fatigue severity and depression scores, and lowers Expanded Disability Status Scale. Benefits attributed to reduced oxidative stress, enhanced mitochondrial function, and anti-inflammatory activity through NFκB inhibition.
Lipid Profile Improvement
ModerateMeta-analysis (8 RCTs, 526 participants) shows CoQ10 supplementation significantly decreases total cholesterol and increases HDL-cholesterol in coronary artery disease patients, with no significant effect on LDL, triglycerides, or Lp(a). Benefit more pronounced with ≥8 weeks supplementation duration. Mechanism involves lipid peroxidation reduction and LCAT enhancement.
Erectile Dysfunction in Hypertension
LimitedRCT (hypertensive males with mild ED) shows 200 mg CoQ10 daily for 3 months improves erectile function and vascular tone through antioxidant protection and vasodilation enhancement. Response notable in mild ED; unclear efficacy in moderate-to-severe ED. Mechanism involves NO bioavailability and endothelial function restoration.
Wound Healing & Tissue Repair
LimitedPilot RCT (30 patients, gum recession surgery) showed trend toward higher mean root coverage (84.6% vs 72.2%) and complete root coverage (60% vs 13.3%) with topical CoQ10 post-operatively, though early wound healing (first 21 days) and pain showed no significant difference. Likely mechanism involves antioxidant and anti-inflammatory activity on healing tissues.
Kidney Disease & CKD Management
LimitedSystematic review evidence indicates CoQ10 supplementation may improve mitochondrial function and reduce oxidative stress in non-dialysis and dialysis CKD patients, with potential to reduce adverse cardiovascular events. Mechanism involves restoration of CoQ10 levels (typically depleted in CKD) and enhanced cellular bioenergetics.
Laatst bijgewerkt: